检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘海涛[1] 戴毅珠 沈菊[1] 卢新华[1] 陈羿[1]
机构地区:[1]江西省九江市第一人民医院,江西九江332000
出 处:《中国医学创新》2015年第14期9-12,共4页Medical Innovation of China
基 金:江西省卫生厅科技计划项目(20143256)
摘 要:目的:探讨40%碘化油及庆大霉素、地塞米松、甲硝唑行腮腺导管灌注治疗对慢性阻塞性腮腺炎的诊断价值,并分析其在慢性阻塞性腮腺炎治疗中的临床价值。方法:选择2011年1月-2014年6月本院收治的慢性阻塞性腮腺炎患者80例,所有患者均经临床表现及X片确诊,按照随机数字表法分为两组,每组各40例。观察组使用40%碘化油及庆大霉素、地塞米松、甲硝唑进行造影和治疗;对照组仅注射总量为3~5 mL的76%的泛影葡胺,全身抗炎治疗。比较两组治疗过程中发生的不良反应、临床诊断率和治疗效果。结果:观察组治疗过程中出现腮腺肿胀、严重疼痛以及腮腺炎症加重的比例显著低于对照组,观察组临床诊断率显著高于对照组,且痊愈率高于对照组,两组比较差异均有统计学意义(P〈0.05)。结论:使用40%碘化油及庆大霉素、地塞米松、甲硝唑造影、治疗,其操作简单、造影显影效果好,无毒无害组织刺激小,在进行造影检查的同时还具有治疗作用。Objective:To investigate the value of 40% iodized oil parotid duct infusion for chronic parotitis. Method:80 cases with chronic mumps in our hospital from January 2011 to June 2014 were choosed, all patients were confirmed by clinical and pathological biopsy, and then all patients were randomly divided into two groups according random number, 40 cases in each group.The observation group were used 40% iodized oil angiography and treatment, the control group were used only the total amount of injection of 3-5 mL of 76% diatrizoate,then the adverse events and clinical diagnosis between the two groups during the treatment were compared.Result:The observation group during the treatment with parotid gland swelling, severe pain, and increase the proportion of mumps disease were lower than control group, the observation group with clinical diagnosis was higher than control group,the recovery rate was higher than control group,the inefficient of observation group was higher than control group, the differences were statistically significant(P〈0.05).Conclusion:40% iodized oil parotid duct infusion for chronic parotitis has simple operation and good angiography revealed,it is nontoxic and it also has a therapeutic effect.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.38